INS and prostate cancer: The role of platelets in breast and prostate cancer has been less intensively investigated, but a recent breast cancer study that correlated U-TXM, urinary markers of oxidative stress and clinical characteristics suggested enhanced oxidative stress due to insulin resistance and oestrogen-related mechanisms may cause platelet activation and a positive environment for tumour growth [49].